Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Study acronym: PRAISE
StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 6 months later May 31, 2027 → Nov 30, 2027
See other at-risk trials from University of Miami

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 31, 2027 to Nov 30, 2027
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints revised (31)
  2. Minor Study completion date: May 31, 2027 to May 31, 2028
    • Start date: Mar 9, 2024 to Mar 19, 2024
    • Site contact updated
    v11
  3. Minor Secondary endpoints: 28 to 31v10
  4. Minor Trial status: Enrolling by Invitation to Recruiting
    • Site details revised
    v9
  5. Notable Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Start date changed from estimate of Jun 1, 2024 to Mar 9, 2024
    • Site contact updated
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Notable Start date: Mar 13, 2024 to Jun 1, 2024v7
  2. Minor Start date: Mar 8, 2024 to Mar 13, 2024v6
  3. Minor Start date: Mar 1, 2024 to Mar 8, 2024v5
  4. Minor Start date: Feb 2, 2024 to Mar 1, 2024v4
  5. Notable Start date: Jan 2, 2024 to Feb 2, 2024v3
  6. Notable Start date: Nov 1, 2023 to Jan 2, 2024v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).
Trial Details
NCT Number NCT06089161
Lead Sponsor University of Miami
Collaborators: National Institute on Aging (NIA)
Conditions
(from sponsor)
Sleep Apnea
Related terms Sleep Apnea Syndromes
Enrollment 330 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov